Abstract: Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
Type:
Grant
Filed:
December 18, 2020
Date of Patent:
September 20, 2022
Assignee:
NUEVOLUTION A/S
Inventors:
Sanne Schrøder Glad, Ian Sarvary, Alex Haahr Gouliaev, Thomas Franch, Søren Jensby Nielsen, Luigi Piero Stasi